Literature DB >> 21940001

[Prevalence of atrial fibrillation and related factors in hospitalized old patients: ESFINGE study].

Alfonso López Soto1, Francesc Formiga, Xavier Bosch, Javier García Alegría.   

Abstract

BACKGROUND AND OBJECTIVES: Atrial fibrillation (AF) is the commonest rhythm abnormality and it increases with ageing. The main objective of this study was to assess the prevalence of AF in hospitalized old patients as well as its characteristics and related clinical and therapeutic factors. PATIENTS AND METHODS: Prospective, multicenter, observational study in patients aged ≥ 70 years with AF, who had been hospitalized in Internal Medicine or Geriatrics wards. All variables studied were obtained from the patients' clinical records.
RESULTS: Out of 3,319 evaluable patients, 922 had an AF, which represents a prevalence of 31.3% (CI 95%; 29.7-32.9). The mean age was 82 years (6.1; 69.9-101.8) and 57% were women. 88.7% of patients (818 p) had an AF before admission. AF was long-standing persistent or permanent in 728 cases (89.1%) and it was the first episode (paroxysmal or persistent) in 51 patients (6.2%). There was a clear etiology of AF in only 4.1% cases. Congestive heart failure was the commonest reason for hospitalization in our patients. Regarding the cardiovascular risk factors, 80.3% patients were hypertensive, 36.4% had dyslipemia, 38.2% had diabetes and 5% were active smokers. Associated diseases included renal insufficiency (38.1%) and chronic obstructive pulmonary disease (38.2%); in addition, 188 patients (20.4%) had suffered from cerebrovascular accidents. Finally, 67.4% patients had received antiarrhythmic drugs for their FA. Although 86.1% had received thromboembolic prevention therapy, only 54.1% were under oral anticoagulation. Finally, 6.9% patients had antiarrhythmic drugs-related side effects.
CONCLUSIONS: Over one third of hospitalized patients older than 70 years have AF, which is generally relapsing and permanent. Heart failure is the commonest reason for hospitalization in these patients and about 40% have an associated disease. Copyright Â
© 2011 Elsevier España, S.L. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21940001     DOI: 10.1016/j.medcli.2011.05.023

Source DB:  PubMed          Journal:  Med Clin (Barc)        ISSN: 0025-7753            Impact factor:   1.725


  7 in total

1.  Influence of frailty on anticoagulant prescription and clinical outcomes after 1-year follow-up in hospitalised older patients with atrial fibrillation.

Authors:  Alejandra Gullón; Francesc Formiga; Jesús Díez-Manglano; José María Mostaza; José María Cepeda; Antonio Pose; Jesús Castiella; Carmen Suárez-Fernández
Journal:  Intern Emerg Med       Date:  2018-09-06       Impact factor: 3.397

Review 2.  Using Direct Oral Anticoagulants in Patients with Atrial Fibrillation: Assessment, Monitoring and Treatment Reversal.

Authors:  Antoni Martínez-Rubio; Mario DiazNuila Alcazar; Anna Soria Cadena; Roger Martínez-Torrecilla
Journal:  Eur Cardiol       Date:  2016-12

3.  Improvement in the Management of Oral Anticoagulation in Patients with Atrial Fibrillation in Primary Health Care.

Authors:  África García-Roy; Ana Sarsa-Gómez; Fátima Méndez-López; Blanca Urdin-Muñoz; María Antonia Sánchez-Calavera
Journal:  Int J Environ Res Public Health       Date:  2022-05-31       Impact factor: 4.614

4.  Comparison of Atrial Fibrillation in the Young versus That in the Elderly: A Review.

Authors:  Rajiv Sankaranarayanan; Graeme Kirkwood; Katharine Dibb; Clifford J Garratt
Journal:  Cardiol Res Pract       Date:  2013-01-22       Impact factor: 1.866

5.  Effectiveness, safety and costs of thromboembolic prevention in patients with non-valvular atrial fibrillation: phase I ESC-FA protocol study and baseline characteristics of a cohort from a primary care electronic database.

Authors:  Maria Giner-Soriano; Cristina Vedia Urgell; Albert Roso-Llorach; Rosa Morros; Dolors Capellà; Xavier Castells; Ignacio Ferreira-González; Amelia Troncoso Mariño; Eduard Diògene; Josep M Elorza; Marc Casajuana; Bonaventura Bolíbar; Concepció Violan
Journal:  BMJ Open       Date:  2016-01-28       Impact factor: 2.692

6.  Handheld ECG Tracking of in-hOspital Atrial Fibrillation The HECTO-AF trial Clinical Study Protocol.

Authors:  Sara Schukraft; Marco Mancinetti; Daniel Hayoz; Yannick Faucherre; Stéphane Cook; Diego Arroyo; Serban Puricel
Journal:  Trials       Date:  2019-01-30       Impact factor: 2.279

7.  Demographic, clinical, and functional determinants of antithrombotic treatment in patients with nonvalvular atrial fibrillation.

Authors:  Jose María Mostaza; Carmen Suarez; Jose María Cepeda; Luis Manzano; Demetrio Sánchez
Journal:  BMC Cardiovasc Disord       Date:  2021-08-09       Impact factor: 2.298

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.